Anixa Biosciences, Inc.
ANIX
$3.38
-$0.17-4.79%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.12% | 2.18% | -7.17% | -30.51% | -37.19% |
| Total Depreciation and Amortization | -25.00% | -30.77% | -25.00% | -72.73% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.64% | -36.82% | -18.63% | 4.92% | 0.91% |
| Change in Net Operating Assets | -69.03% | -72.26% | 299.39% | -385.60% | 73.18% |
| Cash from Operations | -3.23% | -25.77% | 52.92% | -82.91% | -80.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 321.22% | 1,995.35% | 246.21% | 377.96% | 116.14% |
| Cash from Investing | 321.22% | 1,995.35% | 246.21% | 377.96% | 116.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.87% | -- | -- | 6,366.67% | 3,718.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.77% | -100.77% | -- | -- | -- |
| Cash from Financing | -97.99% | -100.75% | -62.01% | 4,866.67% | 1,007.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28,666.67% | -362.65% | 102.01% | 109.50% | 99.93% |